Cryptococcal Meningitis: Comparison of Short- (≤ 1 week) versus Longer-duration (> 1 week) Liposomal Amphotericin B Induction Therapy and Factors Associated with Clinical Outcomes in HIV and non-HIV patients

Clicks: 2
ID: 315951
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #112 of 208 articles by views in Open forum infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 208 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Shorter induction regimens for cryptococcal meningitis (CM) are being proposed, but data from resource-rich countries are limited. We compared clinical outcomes between short- (≤ 1 week) and longer-duration (> 1 week) of liposomal amphotericin B (L-AmB) induction therapy and investigated factors associated with clinical outcomes at a United States medical center. Methods In this retrospective study, cases of CM were identified by a positive cerebrospinal fluid (CSF) culture for Cryptococcus, cryptococcal antigen (CrAg), or India ink stain during 2016-2023. Clinical characteristics and outcomes including Glasgow Outcome Scale (GOS) at discharge, in-hospital mortality, and 90-day readmission between short-duration and longer-duration of L-AmB induction therapy were compared. Multivariable logistic regression was used to identify predictors of Glasgow Outcome Scale (GOS) at discharge and 90-day readmission. Results Of 129 patients, 20 were in the short-duration (11 patients with HIV) and 109 in the longer-duration L-AmB group (72 with HIV). The short-duration group was less severely ill at baseline. Unfavorable GOS at discharge was 50.0% vs. 61.5% (P = 0.34), in-hospital mortality 5.0% vs. 5.5% (P = 0.93), and 90-day readmission 25.0% vs. 38.5% (P = 0.24) in the short-duration and longer-duration groups, respectively. In multivariable analyses, higher CSF CrAg titer, acute kidney injury, and absence of photophobia were associated with unfavorable GOS at discharge, while L-AmB duration was not significantly associated. Association between L-AmB duration and 90-day readmission was inconsistent. Conclusions Short-duration L-AmB may have comparable outcomes to longer-duration in this cohort; further studies are needed to confirm these findings.
Reference Key
openalex_W7163514161 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Sun O. Park, Matthew Stack, Ty C Drake, Rodrigo Hasbun, Luis Ostrosky-Zeichner
Journal Open forum infectious diseases
Year 2026
DOI
10.1093/ofid/ofag342
URL
https://doi.org/10.1093/ofid/ofag342
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.